The interaction between leukocytosis and other risk factors for thrombosis in essential thrombocythemia [1]

Blood

Volumn 109, Issue 9, 2007, Pages 4105-

  Tefferi, Ayalew ^a   Gangat, Naseema ^b   Wolanskyj, Alexandra ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY THROMBOSIS; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; LETTER; LEUKOCYTE COUNT; LEUKOCYTOSIS; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SMOKING; THROMBOCYTHEMIA; THROMBOSIS; VEIN THROMBOSIS;

EID: 34247365425     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-01-066985     Document Type: Letter

References (5)

1. Landolfi R, Di Gennaro L, Barbui T, et al. Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera. Blood. Prepublished November 14, 2006, as DOI: 10.1182/2006-08-042515.
2. Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc 2006;81:159-166.
3. Carobbio A, Finazzi G, Guerini V, et al. Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors and Jak2 mutation status. Blood. Prepublished November 16, 2006, as DOI: 10.1182/2006-09-046342.
4. Gangat N, Wolanskyj AP, McClure RF, et al. Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients. Leukemia. 2007;21:271-276.
5. Gillum RF, Ingram DD, Makuc DM. White blood cell count and stroke incidence and death: the NHANES I epidemiologic follow-up study. Am J Epidemiol. 1994;139:894-902.